Optimal Drug Therapy in the Treatment of Testicular Cancer
- 1 July 1991
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 42 (1) , 52-64
- https://doi.org/10.2165/00003495-199142010-00004
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Risk-related adjuvant chemotherapy for stage I non-seminoma of the testisClinical Oncology, 1991
- Ifosfamide/MesnaDrugs, 1991
- OndansetronDrugs, 1991
- Management of Patients with Poor-Prognosis Nonseminomatous Germ Cell CancerOncology, 1990
- Salvage Therapy in Recurrent Germ Cell Cancer: Ifosfamide and Cisplatin plus Either Vinblastine or EtoposideAnnals of Internal Medicine, 1988
- Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up.Journal of Clinical Oncology, 1988
- Prognostic factors in metastatic testicular cancerInternational Journal of Andrology, 1987
- Tumour Markers in Testicular Germ Cell Tumours Five-Year Experience from the DATECA Study 1976–1980Acta Radiologica: Oncology, 1984
- Return of Fertility After Treatment for Nonseminomatous Testicular Cancer: Changing ConceptsJournal of Urology, 1983
- Chemotherapy of disseminated testicular cancer a random prospective studyCancer, 1980